Antiproliferative factor may offer marker for IC

Alexandria, VA--The search for a sensitive and specific screening tool for interstitial cystitis has been nothing short of elusive.

Related Content:

Drug Therapy

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria